Shomura, M.; Okabe, H.; Sato, E.; Fukai, K.; Shiraishi, K.; Hirose, S.; Tsuruya, K.; Arase, Y.; Anzai, K.; Kagawa, T.
Hypothyroidism Is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy. Cancers 2020, 12, 3078.
https://doi.org/10.3390/cancers12113078
AMA Style
Shomura M, Okabe H, Sato E, Fukai K, Shiraishi K, Hirose S, Tsuruya K, Arase Y, Anzai K, Kagawa T.
Hypothyroidism Is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy. Cancers. 2020; 12(11):3078.
https://doi.org/10.3390/cancers12113078
Chicago/Turabian Style
Shomura, Masako, Haruka Okabe, Emi Sato, Kota Fukai, Koichi Shiraishi, Shunji Hirose, Kota Tsuruya, Yoshitaka Arase, Kazuya Anzai, and Tatehiro Kagawa.
2020. "Hypothyroidism Is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy" Cancers 12, no. 11: 3078.
https://doi.org/10.3390/cancers12113078
APA Style
Shomura, M., Okabe, H., Sato, E., Fukai, K., Shiraishi, K., Hirose, S., Tsuruya, K., Arase, Y., Anzai, K., & Kagawa, T.
(2020). Hypothyroidism Is a Predictive Factor for Better Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Undergoing Lenvatinib Therapy. Cancers, 12(11), 3078.
https://doi.org/10.3390/cancers12113078